ORGATRAX

Post-LOE

hydroxyzine hydrochloride

Merck & Co.

ANDAINJECTIONINJECTABLE

Approved

Jun 1980

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

ORGATRAX (hydroxyzine hydrochloride) by Merck & Co. is clinical pharmacology hydroxyzine hydrochloride is unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines. Approved for anxiety. First approved in 1980.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Hydroxyzine hydrochloride is unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines. Hydroxyzine is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the…

Indications (1)

anxiety

Worked on ORGATRAX at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.